Search results
BioNTech SE (NASDAQ:BNTX) stock most popular amongst private equity firms who own 44%, while...
Simply Wall St. via Yahoo Finance· 1 year agoA look at the shareholders of BioNTech SE (NASDAQ:BNTX) can tell us which group is most powerful....
BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoBioNTech SE Sponsored ADR (BNTX) closed the most recent trading day at $131.54, moving +0.59% from...
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoBioNTech (NASDAQ:BNTX) has had a rough three months with its share price down 28%. However, a closer...
Is BioNTech SE's (NASDAQ:BNTX) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that BioNTech's (NASDAQ:BNTX) stock increased significantly by...
BioNTech Trims Expenses As Plummeting Covid Vaccine Sales Still Lag Expectations
Investor's Business Daily· 10 months agoGerman biotech BioNTech said Monday it's trimming drug development costs amid plummeting Covid...
BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics
Zacks via Yahoo Finance· 2 years agoBioNTech (BNTX) signs a research collaboration agreement with Ryvu Therapeutics to develop small...
Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On Upgrade
Investor's Business Daily· 2 years agoBioNTech snagged an upgrade Wednesday with an analyst saying "Covid fatigue" has obscured its...
BioNTech Shares Up On Hope For Combined Flu, Covid Shot
Investor's Business Daily· 2 years agoPfizer and BioNTech started testing a combined flu and Covid vaccine on Thursday, helping BNTX stock...
Individual investors own 21% of BioNTech SE (NASDAQ:BNTX) shares but private equity firms control...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls BioNTech SE (NASDAQ:BNTX), then you'll have to look at the...
BioNTech Pares Losses After Doubling Profits, Raising 2022 Guidance
Investor's Business Daily· 2 years agoBioNTech doubled Wall Street's third-quarter profit expectations Monday and raised its full-year...